PALI

PALISADE BIO, INC.

Healthcare · Biotechnology

$97.19 sample

+1.07 (+1.11%) 1D

Market cap

$525.8B

Price as of

2026-10-16

Latest filing

8-K · 2026-09-10

Alerts

8

Price$97.19 +0.47% 3M daily closessample

106.9290.59

2026-07-212026-08-122026-09-032026-09-242026-10-16

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: Director
Oct 02INSInsider sell: Director
Sep 28INSInsider sell: Director
Sep 17INSInsider buy: Chief Executive Officer
Sep 10SECForm 144 filed
Sep 03SECForm 144 filed
Aug 26SECForm 144 filed
Aug 20SECDEF 14A filed

Sign up to see the real PALI record →

Company facts

SEC EDGAR registration

Name: PALISADE BIO, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -15sample, -100 to +100
Reporting currency: USD

Who is positioning in PALI

sample

Insiders: 7 insider transactions over 90 days, net selling, $354.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 6 funds hold $11.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.3B +18.1% y/y

Q4 2024Q3 2026

Inventory$10.4B +4.5% y/y

Q4 2024Q3 2026

Accounts receivable$8.0B +8.8% y/y

Q4 2024Q3 2026

Total debt$21.9B +9.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $203.0B +13.5% 3M
Sample peer B: $423.8B -4.6% 3M
Sample peer C: $68.7B -10.9% 3M
Sample peer D: $453.6B -2.1% 3M
Sample peer E: $468.9B +12.5% 3M